IMU Biosciences
Profiles human immune systems using multi-omic analysis and machine learning for disease research.
$53MSeries A
Role not disclosedBB
British Business Bank
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
British Business Bank is the UK’s economic development bank, supporting business access to finance through investment programmes, funds and financing partners.
Its Future Fund: Breakthrough programme, delivered by British Patient Capital, co-invests with private investors in later-stage, R&D-intensive UK companies. It targets technologies such as quantum computing, cleantech and life sciences, where development requires substantial capital.
Applications to that programme come from a qualifying sponsor investor, rather than directly from the company. The published criteria require a round of at least £30 million, with the programme contributing no more than 30% on the sponsor investor’s terms.
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $53.5M 2 disclosed · full round size, not this investor’s share